Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5917.06 | 2641 / 2642 | 100% | 27.64 | 705 / 705 |
prostate | 99% | 3503.02 | 242 / 245 | 100% | 20.44 | 501 / 502 |
thymus | 99% | 2300.95 | 647 / 653 | 98% | 9.17 | 590 / 605 |
adrenal gland | 97% | 1874.24 | 251 / 258 | 90% | 7.81 | 207 / 230 |
kidney | 100% | 1925.36 | 89 / 89 | 83% | 5.68 | 749 / 901 |
lung | 99% | 2556.49 | 570 / 578 | 76% | 5.60 | 882 / 1155 |
pancreas | 95% | 1809.53 | 313 / 328 | 78% | 5.65 | 139 / 178 |
esophagus | 99% | 2689.47 | 1425 / 1445 | 67% | 4.07 | 123 / 183 |
breast | 87% | 1243.17 | 400 / 459 | 77% | 8.72 | 858 / 1118 |
uterus | 100% | 7653.49 | 170 / 170 | 62% | 5.29 | 283 / 459 |
ovary | 100% | 7050.91 | 180 / 180 | 54% | 2.98 | 234 / 430 |
bladder | 100% | 2770.33 | 21 / 21 | 47% | 2.81 | 235 / 504 |
stomach | 96% | 1994.15 | 345 / 359 | 48% | 2.78 | 137 / 286 |
intestine | 95% | 2002.86 | 914 / 966 | 44% | 2.53 | 230 / 527 |
skin | 54% | 618.89 | 972 / 1809 | 84% | 11.14 | 396 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.29 | 29 / 29 |
spleen | 100% | 3588.14 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4124.04 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 10957.59 | 845 / 861 | 0% | 0 | 0 / 0 |
adipose | 87% | 1209.72 | 1052 / 1204 | 0% | 0 | 0 / 0 |
liver | 64% | 780.28 | 144 / 226 | 19% | 1.12 | 78 / 406 |
tonsil | 0% | 0 | 0 / 0 | 82% | 5.73 | 37 / 45 |
eye | 0% | 0 | 0 / 0 | 66% | 13.41 | 53 / 80 |
muscle | 52% | 864.01 | 419 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 39% | 1651.14 | 363 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035970 | Biological process | peptidyl-threonine dephosphorylation |
GO_1902108 | Biological process | regulation of mitochondrial membrane permeability involved in apoptotic process |
GO_0009083 | Biological process | branched-chain amino acid catabolic process |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0030145 | Molecular function | manganese ion binding |
GO_0047385 | Molecular function | [3-methyl-2-oxobutanoate dehydrogenase (lipoamide)]-phosphatase activity |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004722 | Molecular function | protein serine/threonine phosphatase activity |
Gene name | PPM1K |
Protein name | Protein phosphatase, Mg2+/Mn2+ dependent 1K Protein phosphatase Mn(2+)-dependent 1K (EC 3.1.3.16) (EC 3.1.3.52) (Branched-chain alpha-ketoacid dehydrogenase phosphatase) (Protein phosphatase 2C family member) Protein phosphatase 1G protein-serine/threonine phosphatase (EC 3.1.3.16) Protein phosphatase Mn(2+)-dependent 1K (EC 3.1.3.16) (Branched-chain alpha-ketoacid dehydrogenase phosphatase) (BCKDH) (BDP) (EC 3.1.3.52) (PP2C domain-containing protein phosphatase 1K) (PP2C-like mitochondrial protein) (PP2C-type mitochondrial phosphoprotein phosphatase) (PTMP) (Protein phosphatase 2C family member) (Protein phosphatase 2C isoform kappa) (PP2C-kappa) ([3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring)]-phosphatase, mitochondrial) |
Synonyms | PP2CM hCG_39060 |
Description | FUNCTION: Serine/threonine-protein phosphatase component of macronutrients metabolism. Forms a functional kinase and phosphatase pair with BCKDK, serving as a metabolic regulatory node that coordinates branched-chain amino acids (BCAAs) with glucose and lipid metabolism via two distinct phosphoprotein targets: mitochondrial BCKDHA subunit of the branched-chain alpha-ketoacid dehydrogenase (BCKDH) complex and cytosolic ACLY, a lipogenic enzyme of Krebs cycle . At high levels of branched-chain ketoacids, dephosphorylates and activates mitochondrial BCKDH complex, a multisubunit complex consisting of three multimeric components each involved in different steps of BCAA catabolism: E1 composed of BCKDHA and BCKDHB, E2 core composed of DBT monomers, and E3 composed of DLD monomers. Tightly associates with the E2 component of BCKDH complex and dephosphorylates BCKDHA on Ser-337 . Regulates the reversible phosphorylation of ACLY in response to changes in cellular carbohydrate abundance such as occurs during fasting to feeding metabolic transition. At fasting state, appears to dephosphorylate ACLY on Ser-455 and inactivate it. Refeeding stimulates MLXIPL/ChREBP transcription factor, leading to increased BCKDK to PPM1K expression ratio, phosphorylation and activation of ACLY that ultimately results in the generation of malonyl-CoA and oxaloacetate immediate substrates of de novo lipogenesis and gluconeogenesis, respectively . Recognizes phosphosites having SxS or RxxS motifs and strictly depends on Mn(2+) ions for the phosphatase activity . Regulates Ca(2+)-induced opening of mitochondrial transition pore and apoptotic cell death . . |
Accessions | V9GYI6 ENST00000510548.6 V9GYZ5 ENST00000608933.6 [Q8N3J5-1] A0A0A0MQZ4 V9GY69 ENST00000514204.1 Q8N3J5 V9GYS8 ENST00000505022.1 ENST00000508256.5 ENST00000295908.11 |